49(P07) ムスカリンM_2サブタイプレセプターアンタゴニスト(+)-ヒンバシンの全合成(ポスター発表の部)
スポンサーリンク
概要
- 論文の詳細を見る
(+)-Himbacine (1), which is a piperidine alkaloid isolated from the bark of Galbuliminza Bacrata, bears a charactaristic structural feature in which the tricyclic part, consisting of cis-fused γ-lactone and trans-fused decaline moieties, is connected with trans-disubstituted piperidine via an (E)-double bond. It is reported that 1 behaves as a potent antagonist of the muscarinic receptor of M_2 subtype with 20-fold selectivity toward the M_1 receptor. Thus, blockage of the presynaptic muscarinic receptor of M_2 subtype leads to an elevation of the synaptic levels of acetylcholine, possibly offsetting some of the losses in the cholinergic system that occurs in Alzheimer' s disease. The two total syntheses of 1 have hitherto been achieved by employing an intramolecular Diels-Alder reaction as the key step. In order to disclose novel aspects of the structure-activity relationships of 1 and, moreover, to explore the promising congeners of 1 which may show more improved M_2 subtype selectivity, an efficient synthetic route to 1 was sought which is more convergent and flexible than those reported. Aiming to make the synthesis of variety analogues of himbacine possible, our synthetic route to 1 was designed by employing the intermolecular Diels-Alder reaction of the tetrahydroisobenzofuran 5 with the chiral butenolide 6 as the key step. It is generally accepted that an intermolecular Diels-Alder reaction is more convergent and flexible than an intramolecular one, especially for the synthesis of complex natural products. After experimentation, we found that the expected intermolecular Diels-Alder reaction of 5 with 6 takes place in ether containing LiClO_4 (5M solution), giving rise to 4 as the sole isolable product. It appeared evident that, probably due to steric and electronic reasons, the intermolecular Diels-Alder reaction proceeds in a highly stereoselective and diastereoselective manner, exclusively producing the exo-adduct. Hydrogenation of the double bond in 4 was afforded the saturated compound 7. This was subjected to base-induced β-elimination of the oxygen bridge followed by double bond isomerization, affording the unsaturated alcohol 9 as the sole product. Stereoselective catalytic reduction of 9 over PtO_2 smoothly gave the saturated tricyclic alcohol 10a. Thus, stereoselective construction of the decahydronaphtho[2,3-c]furan system involved in 1 was readily furnished in 4 steps from the Diels-Alder exo-cycloadduct 4. After the lactone carbonyl group in 10a was protected, the hydroxy group in the acetal 11 was oxidized. Methylenation and sequential hydroboration and oxidation of 13 gave rise to the β-methyl alcohol 14a stereoselectively, which carried all of the desired chiral centers in the tricyclic part of 1. Next, according to the known protpcol, 14a was transformed to the sulfone 2. Following the reported procedure, 2 was finally converted to 1 in 5 steps. Physical and spectral properties of the synthetic sample of 1 were found to be identical to those reported. Following the same sequence, preparation of the enantiomer of 1 (ent-1) was accomplished starting with (-)-6. In summary, we have developed a novel synthetic route to (+)-himbacine (1), a potent antagonist of the muscarinic receptor of M_2 subtype, by employing an intermolecular Diels-Alder reaction of 5 with 6 as the key step. The explored synthetic scheme which is anticipated to be highly convergent and flexible, may be applicable to the synthesis of various structural types of the novel congeners of 1.
- 天然有機化合物討論会の論文
- 1999-09-01
著者
-
寺島 孜郎
相模中研
-
加藤 正
相模中研
-
高土居 雅法
杏林製薬(株)創薬研
-
河合 智之
杏林製薬(株)創薬研
-
高土居 雅法
杏林製薬中研
-
河合 智之
杏林製薬中研
-
石渡 明弘
相模中研
-
石渡 明弘
理研
関連論文
- P-58 5-ビニルチオラクトマイシン類の両対掌体の合成とその生物活性(ポスター発表の部)
- P-20 2-アミノイミダゾール-4-アルデヒド誘導体の新合成法の開発とそのアルカロイド合成への応用(ポスター発表の部)
- 30 細菌由来N-結合型糖タンパク質糖鎖の立体選択的合成(口頭発表の部)
- P-42 グラム陰性菌Campylobacter jejuni由来N-結合型糖タンパク質糖鎖の立体選択的合成研究(ポスター発表の部)
- 10 制癌活性物質カルチノフィリンの合成研究(口頭発表の部)
- 8 光学活性FR900482の合成研究(口頭発表の部)
- 52 光学活性キノカルシンの合成研究(口頭発表の部)
- 38 ネオカルチノスタチンクロモフォア関連化合物の合成研究(口頭発表の部)
- 58(P1-6) 14-フロロアントラサイクリン類の合成とその制癌活性(ポスター発表の部)
- 14-Fluoroanthracyclines. : Novel Syntheses and Antitumor Activity
- 18 ノガラマイシン類の全合成(口頭発表の部)
- 66 天然型(+)-セスバニミドAおよび(-)-セスバニミドBの全合成
- Novel Synthesis of Three Types of C-Terminal Components of Renin Inhibitors from Unnatural(2S, 3S)-Tartaric Acid
- 67 光学活性カルバペネム鍵合成中間体の合成研究(口頭発表の部)
- 65 生合成仮説を考慮した除草活性物質(+)-ヒダントサイジンの合成(ポスター発表の部)
- P-1 抗生物質(R)-(+)-チオラクトマイシンの全合成(ポスター発表の部)
- 12 ヒンバシン類縁体の合成とそのムスカリンM_2サブタイプ受容体拮抗作用(口頭発表の部)
- 118(P-52) ロゼオフィリンの全合成研究(ポスター発表の部)
- 効率的合成法の開発に感動と興奮を求めて
- 49(P07) ムスカリンM_2サブタイプレセプターアンタゴニスト(+)-ヒンバシンの全合成(ポスター発表の部)
- 生物活性物質の効率的合成法の開発とその創薬化学への展開
- 30 トポイソメラーゼ-II阻害活性を有する海綿由来ポポロフアノンEの全合成研究(口頭発表の部)
- 92(P08) 光学活性(-)-フペルジンAおよびその含フッ素類縁体の合成研究(ポスター発表の部)
- P-34 光学活性デュオカルマイシンAおよびその類縁体の合成と抗腫瘍活性(ポスター発表の部)
- キノカルシンの全合成
- エンイン構造を有する制癌活性天然物の合成研究
- A Highly Stereoselective Synthesis of (3S, 4S)-Statine and (3S, 4S)-Cyclohexylstatine
- 生物活性物質の合成研究--最近の進歩
- 91 デュオカルマイシン類の合成研究(口頭発表の部)
- Synthesis of Novel 13-Methyl-13-dihydroanthracyclines
- Synthesis of 4-Demethoxyanthracyclines Carrying a Lipophilic Alkanoyl Group at the C_9-Position
- 40 光学活性4-デメトキシアドリアマイシン及び4-デメトキシダウノルビシンの全合成研究
- 9 中性スフィンゴミエリナーゼ阻害剤(+)-スキホスタチンの全合成(口頭発表の部)
- Asymmetric Reduction of 4-Phenyl-3 (E)-buten-2-one by Using Lithium Aluminum Hydride Partially Decomposed with (-)-N-Methylephedrine and Achiral Secondary Amine
- Lithium Aluminum Hydride Partially Decomposed with (-)-N-Methylephedrine and 2-Alkylaminopyridine : An Improved Chiral Hydride Useful for the Practical Asymmetric Reduction of Achiral Cyclic Ketones
- キノカルシンの全合成
- エンイン構造を有する制癌活性天然物の合成研究
- Synthesis of Novel Monobactams Bearing an (R)-1-Hydroxyethyl Group and an (S)-1-Carbamoyl-oxyethyl Group at the C_-Positions
- 光学活性な生物活性化合物の合成研究
- ノガラマイシン類の全合成
- 1β-メチルカルバペネム鍵合成中間体の合成
- セスバニミド類の合成
- 31 NAPエーテルを利用した分子内アグリコン転移反応の開発と複合糖質糖鎖合成への応用(口頭発表の部)
- 23 立体選択的アラビノフラノシル化反応の開発とミコバクテリア由来分岐オリゴアラビノフラノシド合成(口頭発表の部)